LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Peptide containing doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

3-dehydroquinate synthase

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

3-Halovinylglycine antibacterial agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

3-hydroxy-2(1H)-pyridinone chelating agents

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

3-L-(5-thioxo-L-prolyl)thiazolidine-4-carboxylic acid and deriva

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

38-decarboxy-38-hydroxymethyl derivatives of teiocoplanin antibi

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

4'-Methyl-.beta.-mercapto-.beta.,.beta.-cyclopentamethylenepropi

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

4-Substituted-2-azetidinone compound, process of producing the c

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

49 human secreted proteins

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

4H-3,1-benzoxazin-4-ones and related compounds and use as enzyme

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

5-amino-4-hydroxyhexanoic acid derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

5-aminosalicylic acid derivatives for the therapy of chronic inf

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

5-lipoxygenase-activating protein II

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

5-lipoxygenase-activating protein II

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

5-substituted amino-4-hydroxy-pentanoic acid derivatives and the

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

6-pen-vasopressin compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

6-position cyclosporin a analogs as modifiers of cytotoxic drug

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

6-position modified decapeptide LHRH antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

60A protein-induced morphogenesis

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

78 residue polypeptide (NK-lysine) and its use